Agilent Technologies, Inc. (0HAV.L)

USD 136.25

(-0.67%)

Total Debt Summary of Agilent Technologies, Inc.

  • Agilent Technologies, Inc.'s latest annual total debt in 2023 was 2.73 Billion USD , down -1.23% from previous year.
  • Agilent Technologies, Inc.'s latest quarterly total debt in 2024 Q2 was 2.89 Billion USD , up 6.51% from previous quarter.
  • Agilent Technologies, Inc. reported annual total debt of 2.76 Billion USD in 2022, up 1.47% from previous year.
  • Agilent Technologies, Inc. reported annual total debt of 2.72 Billion USD in 2021, up 15.68% from previous year.
  • Agilent Technologies, Inc. reported quarterly total debt of 2.71 Billion USD for 2024 Q1, down -0.59% from previous quarter.
  • Agilent Technologies, Inc. reported quarterly total debt of 2.93 Billion USD for 2024 Q3, up 7.6% from previous quarter.

Annual Total Debt Chart of Agilent Technologies, Inc. (2023 - 1998)

Historical Annual Total Debt of Agilent Technologies, Inc. (2023 - 1998)

Year Total Debt Total Debt Growth
2023 2.73 Billion USD -1.23%
2022 2.76 Billion USD 1.47%
2021 2.72 Billion USD 15.68%
2020 2.35 Billion USD -1.99%
2019 2.4 Billion USD 33.8%
2018 1.79 Billion USD -10.54%
2017 2.01 Billion USD 5.18%
2016 1.91 Billion USD 15.53%
2015 1.65 Billion USD -40.08%
2014 2.76 Billion USD 2.33%
2013 2.69 Billion USD 14.27%
2012 2.36 Billion USD 8.1%
2011 2.18 Billion USD -40.8%
2010 3.69 Billion USD 27.1%
2009 2.9 Billion USD 36.66%
2008 2.12 Billion USD 1.82%
2007 2.08 Billion USD 39.13%
2006 1.5 Billion USD 0.0%
2005 - USD -100.0%
2004 1.15 Billion USD 0.0%
2003 1.15 Billion USD 0.0%
2002 1.15 Billion USD 19066.67%
2001 6 Million USD -94.55%
2000 110 Million USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%

Peer Total Debt Comparison of Agilent Technologies, Inc.

Name Total Debt Total Debt Difference
Editas Medicine, Inc. 36.53 Million USD -7385.767%
Dynavax Technologies Corporation 256.91 Million USD -964.559%
Supernus Pharmaceuticals, Inc. 41.52 Million USD -6486.077%
Perrigo Company plc 4.07 Billion USD 32.857%
Illumina, Inc. 2.26 Billion USD -20.911%
Thermo Fisher Scientific Inc. 34.91 Billion USD 92.167%
Iovance Biotherapeutics, Inc. 1 Million USD -273400.0%
Walgreens Boots Alliance, Inc. 9.55 Billion USD 71.373%
IQVIA Holdings Inc. 14.23 Billion USD 80.781%
Heron Therapeutics, Inc. 173.75 Million USD -1474.074%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD -1.188%
Unity Biotechnology, Inc. 26.99 Million USD -10033.383%
Waters Corporation 2.35 Billion USD -16.111%
Biogen Inc. 7.33 Billion USD 62.729%
Sangamo Therapeutics, Inc. 38.1 Million USD -7077.724%
Evolus, Inc. 126.54 Million USD -2061.269%
Adicet Bio, Inc. 17.7 Million USD -15349.359%
Cara Therapeutics, Inc. 43.16 Million USD -6235.858%
bluebird bio, Inc. 330.32 Million USD -727.97%
Esperion Therapeutics, Inc. 540.94 Million USD -405.595%
FibroGen, Inc. 170.45 Million USD -1504.529%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD -12996.005%
Homology Medicines, Inc. 44.05 Million USD -6108.29%
Geron Corporation 85.89 Million USD -3083.972%
Alnylam Pharmaceuticals, Inc. 2.39 Billion USD -14.053%
Amicus Therapeutics, Inc. 445.05 Million USD -514.525%
Myriad Genetics, Inc. 145 Million USD -1786.207%
Viking Therapeutics, Inc. 1.26 Million USD -216963.492%
Intellia Therapeutics, Inc. 115.34 Million USD -2271.127%
Zoetis Inc. 6.8 Billion USD 59.797%
Abeona Therapeutics Inc. 4.4 Million USD -62030.85%
Mettler-Toledo International Inc. 2.16 Billion USD -26.167%
BioMarin Pharmaceutical Inc. 1.13 Billion USD -141.208%
Vertex Pharmaceuticals Incorporated 808.4 Million USD -238.323%
Kala Pharmaceuticals, Inc. 36.32 Million USD -7429.664%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD -88.161%
Atara Biotherapeutics, Inc. 57.87 Million USD -4625.947%
Verastem, Inc. 41.55 Million USD -6481.322%
Nektar Therapeutics 230.4 Million USD -1087.061%
Axsome Therapeutics, Inc. 186.37 Million USD -1367.495%
Aclaris Therapeutics, Inc. 3.07 Million USD -88872.023%
Sarepta Therapeutics, Inc. 1.39 Billion USD -95.804%
OPKO Health, Inc. 326.56 Million USD -737.508%
Exelixis, Inc. 189.94 Million USD -1339.898%
Neurocrine Biosciences, Inc. 428.4 Million USD -538.422%
Corcept Therapeutics Incorporated 151 Thousand USD -1811158.278%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 138.4 Million USD -1876.028%
Imunon, Inc. 1.13 Million USD -239961.161%
Blueprint Medicines Corporation 774.12 Million USD -253.303%
Insmed Incorporated 1.2 Billion USD -127.161%
Halozyme Therapeutics, Inc. 1.49 Billion USD -82.425%
Agios Pharmaceuticals, Inc. 56.98 Million USD -4699.256%
TG Therapeutics, Inc. 110.79 Million USD -2368.523%
Incyte Corporation 38.28 Million USD -7043.417%
Emergent BioSolutions Inc. 877.5 Million USD -211.681%